84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]游翔宇,王想福,葉丙霖,等.補(bǔ)腎活血藥治療骨質(zhì)疏松癥的研究進(jìn)展[J].中醫(yī)正骨,2021,33(03):56-57.
 YOU Xiangyu,WANG Xiangfu,YE Binglin,et al.Advancement of research on Bushen Huoxue(補(bǔ)腎活血)drugs for treatment of osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(03):56-57.
點(diǎn)擊復(fù)制

補(bǔ)腎活血藥治療骨質(zhì)疏松癥的研究進(jìn)展()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第33卷
期數(shù):
2021年03期
頁碼:
56-57
欄目:
綜 述
出版日期:
2021-03-20

文章信息/Info

Title:
Advancement of research on Bushen Huoxue(補(bǔ)腎活血)drugs for treatment of osteoporosis
作者:
游翔宇王想福葉丙霖陳偉國趙恒張萬乾
(1.甘肅中醫(yī)藥大學(xué),甘肅 蘭州 730000; 2.甘肅省中醫(yī)院,甘肅 蘭州 730050)
Author(s):
YOU XiangyuWANG XiangfuYE BinglinCHEN WeiguoZHAO HengZHANG Wanqian
關(guān)鍵詞:
骨質(zhì)疏松 補(bǔ)腎 活血 藥理作用 綜述
摘要:
骨質(zhì)疏松癥(osteoporosis,OP)是骨科常見疾病,發(fā)病機(jī)制復(fù)雜。臨床上應(yīng)用補(bǔ)腎活血藥治療OP療效顯著,但其作用機(jī)制尚不明確。本文從單味藥物和復(fù)方藥物兩個(gè)方面對補(bǔ)腎活血藥治療OP的應(yīng)用現(xiàn)狀進(jìn)行了總結(jié),從激活Wnt/β-catenin信號通路、調(diào)控骨髓間充質(zhì)干細(xì)胞向成骨細(xì)胞分化、上調(diào)轉(zhuǎn)化生長因子的表達(dá)幾個(gè)方面對補(bǔ)腎活血藥治療OP作用機(jī)制的研究進(jìn)展進(jìn)行了綜述。

參考文獻(xiàn)/References:

[1] 遲利業(yè),原超,盧義,等.淫羊藿含藥血清對BMSCs中Sirt1mRNA的表達(dá)的影響[J].時(shí)珍國醫(yī)國藥,2018,29(11):2575-2577.
[2] 郭威.丹參酮ⅡA對大鼠骨髓間充質(zhì)干細(xì)胞成骨分化影響的實(shí)驗(yàn)研究[D].錦州:遼寧醫(yī)學(xué)院,2012.
[3] 馬江濤,萬雷,黃宏興.基于網(wǎng)絡(luò)藥理學(xué)探討骨碎補(bǔ)治療骨質(zhì)疏松癥的作用機(jī)制[J].中國骨質(zhì)疏松雜志,2020,26(4):490-496.
[4] 陳偉國,王想福,葉丙霖,等.二仙湯聯(lián)合經(jīng)皮球囊擴(kuò)張椎體后凸成形術(shù)治療絕經(jīng)后骨質(zhì)疏松性椎體壓縮性骨折臨床研究[J].中國中醫(yī)藥信息雜志,2019,26(6):14-18.
[5] 李智奎,孔俊博,趙王林.補(bǔ)腎活血方輔助治療對絕經(jīng)后骨質(zhì)疏松患者炎性因子及骨代謝指標(biāo)的影響[J].中國老年學(xué)雜志,2020,40(9):1901-1904.
[6] 周潔,林松青,王彬.補(bǔ)腎活血方治療老年性骨質(zhì)疏松癥35例臨床觀察[J].湖南中醫(yī)雜志,2018,34(5):11-13.
[7] 吳海艷,王旭.參芪補(bǔ)腎活血方治療糖尿病性骨質(zhì)疏松的臨床觀察[J].遼寧中醫(yī)雜志,2018,45(11):2314-2317.
[8] 馬威,潘靜,胡必成,等.補(bǔ)腎活血中藥對骨質(zhì)疏松大鼠Wnt信號的影響[J].中國骨質(zhì)疏松雜志,2015,21(7):820-823.
[9] 許兵,金紅婷,劉慧,等.補(bǔ)腎活血顆粒對去勢大鼠骨組織Wnt/β-Catenin通路的影響研究[J].中華中醫(yī)藥雜志,2013,28(11):3400-3405.
[10] 王大偉,鄭洪新.基于Wnt信號通路探討補(bǔ)腎益氣活血中藥復(fù)方對去卵巢大鼠骨質(zhì)疏松癥的作用機(jī)制[J].中國骨質(zhì)疏松雜志,2019,25(5):595-599.
[11] LI M,IKEHARA S.Bone-marrow-derived mesenchymal stem cells for organ repair[J].Stem Cells International,2013
[2020-10-06]. https://pubmed.ncbi.nlm.nih.gov/23554816/.
[12] 卞琴,沈自尹,王擁軍.骨髓間充質(zhì)干細(xì)胞在中醫(yī)理論中的歸屬[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2011,17(7):794-797.
[13] 賴滿香,廖利平,譚瑋璐,等.“腎精-骨質(zhì)疏松-骨髓間充質(zhì)干細(xì)胞”理論探討[J].中醫(yī)雜志,2018,59(2):100-103.
[14] 衛(wèi)榮,魏琴,孟慶才.補(bǔ)腎活血方誘導(dǎo)大鼠骨髓間充質(zhì)干細(xì)胞成骨分化的實(shí)驗(yàn)研究[J].時(shí)珍國醫(yī)國藥,2018,29(8):1807-1810.
[15] 李楊,張延輝,王云楓,等.丹參提取物促進(jìn)骨髓間充質(zhì)干細(xì)胞增殖及成骨分化的研究[J].中國骨質(zhì)疏松雜志,2017,23(8):1030-1033.
[16] 梁廣勝,陳偉才,殷嫦嫦,等.淫羊藿總黃酮對大鼠骨髓間充質(zhì)干細(xì)胞成骨分化過程BMP-2/RunX2/OSX通路的影響[J].中國中西醫(yī)結(jié)合雜志,2016,36(5):614-618.
[17] 戰(zhàn)美,鄧雪,朱迪,等.女貞子提取物及其成分促骨髓間充質(zhì)干細(xì)胞成骨分化的作用[J].中華中醫(yī)藥雜志,2018,33(7):2803-2806.
[18] ROBERTS A B,ANZANO M A,LAMB L C,et al.New class of transforming growth factors potentiated by epidermal growth factor:isolation from non-neoplastic tissues[J].Proc Natl Acad Sci USA,1981,78(9):5339-5343.
[19] 劉麗鵬,吳潔.轉(zhuǎn)化生長因子-β與絕經(jīng)后骨質(zhì)疏松癥關(guān)系研究進(jìn)展[J].中國實(shí)用婦科與產(chǎn)科雜志,2011,27(5):386-388.
[20] 王凱,宋敏,文皓楠,等.轉(zhuǎn)化生長因子-β在骨代謝中作用機(jī)制的研究進(jìn)展[J].中國骨質(zhì)疏松雜志,2020,26(2):308-312.
[21] 尚立芝,王付,李沛.補(bǔ)腎方藥對骨質(zhì)疏松大鼠白細(xì)胞介素-1、腫瘤壞死因子-α及轉(zhuǎn)化生長因子-β1的影響[J].中華中醫(yī)藥雜志,2012,27(12):3237-3239.
[22] 韓麗萍,王相東,魏敏惠,等.補(bǔ)腎活血方對骨質(zhì)疏松癥大鼠TGF-β1表達(dá)影響的拆方研究[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2013,19(3):264-265.
[23] 曲雷鳴,龔偉.鹿茸干預(yù)去卵巢骨質(zhì)疏松癥模型大鼠的實(shí)驗(yàn)評價(jià)[J].實(shí)驗(yàn)動物與比較醫(yī)學(xué),2019,39(1):52-55.(收稿日期:2020-09-15 本文編輯:楊雅)

相似文獻(xiàn)/References:

[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的 胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補(bǔ)腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
 HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補(bǔ)腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):7.
[3]李學(xué)朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
 LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):12.
[4]陳冠軍,陳揚(yáng),莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng) 在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[5]趙如意,劉克鋒,李沛.經(jīng)筋針刺配合中藥外敷治療運(yùn)動員髕骨軟化癥[J].中醫(yī)正骨,2015,27(01):54.
[6]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
 Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):27.
[7]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證 患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
 Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(03):19.
[8]項(xiàng)旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
 Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(03):20.
[9]史曉林,李春雯,張志強(qiáng).弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時(shí)間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
 Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):5.
[10]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機(jī)制研究[J].中醫(yī)正骨,2014,26(09):21.
 Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):21.

備注/Memo

備注/Memo:
基金項(xiàng)目:甘肅省科技計(jì)劃項(xiàng)目(18JR3RA067,20JR10RA357)
通訊作者:王想福 E-mail:[email protected]
更新日期/Last Update: 1900-01-01